lenvatinib and 6-methyladenine

lenvatinib has been researched along with 6-methyladenine* in 1 studies

Other Studies

1 other study(ies) available for lenvatinib and 6-methyladenine

Article	Year
METTL3-m Cancer letters, 2023, 04-10, Volume: 559 Lenvatinib is emerging as the first-line therapeutic option for advanced hepatocellular carcinoma (HCC), but drug resistance remains a major hurdle for its long-term therapy efficiency in clinic. N Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Liver Neoplasms; Methyltransferases; Mice; RNA, Messenger	2023

Article

Year

Cancer letters, 2023, 04-10, Volume: 559

Lenvatinib is emerging as the first-line therapeutic option for advanced hepatocellular carcinoma (HCC), but drug resistance remains a major hurdle for its long-term therapy efficiency in clinic. N

Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Liver Neoplasms; Methyltransferases; Mice; RNA, Messenger

2023